Investing

Immunocore : IMCR

IMCR

Stock Data

$28.11

$0.65 (2.27%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Immunocore Holdings plc is a pioneering biotechnology firm focused on creating innovative immunotherapies to combat cancer, infectious diseases, and autoimmune disorders. Its flagship product, KIMMTRAK, offers hope to patients with advanced uveal melanoma. The company is actively developing a range of treatments targeting various cancers, including melanoma, lung cancer, and ovarian cancer, through clinical trials. Additionally, Immunocore is exploring treatments for infectious diseases like hepatitis B and HIV, as well as autoimmune diseases, leveraging its expertise in immune system modulation. Founded in 1999, Immunocore is based in Abingdon, the United Kingdom.

All Immunocore Articles

1 Article

Lee Jackson | Mar 16, 2026 at 7:38 AM EDT

Here Are Monday’s Top Wall Street Analyst Research Calls: Alnylam Pharmaceuticals, Circle Internet, Fifth Third Bancorp, Intuit, ServiceNow, Qualcomm, Trade Desk, and More

Pre-Market Stock Futures: The futures are trading higher as we start the new trading week. There is an old saying,…